JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 163 filers reported holding JUNO THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 2.35 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $615,000 | +20.6% | 13,463 | +18.5% | 0.00% | +33.3% |
| Q3 2017 | $510,000 | +84.8% | 11,365 | +23.7% | 0.00% | +50.0% |
| Q3 2016 | $276,000 | -19.1% | 9,191 | +3.6% | 0.00% | -33.3% |
| Q2 2016 | $341,000 | +11.1% | 8,871 | +10.0% | 0.00% | -25.0% |
| Q1 2016 | $307,000 | -30.4% | 8,067 | -25.5% | 0.00% | -42.9% |
| Q3 2015 | $441,000 | – | 10,830 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,055,857,000 | 100.00% |
| Omega Fund Management, LLC | 1,329,512 | $54,098,000 | 30.46% |
| SOUND ENERGY PARTNERS, INC. | 25,800 | $1,050,000 | 2.12% |
| Graticule Asia Macro Advisors LLC | 435,205 | $17,708,000 | 2.06% |
| BB BIOTECH AG | 1,305,000 | $53,100,000 | 1.68% |
| Kazazian Asset Management, LLC | 13,376 | $544,000 | 0.69% |
| Rock Springs Capital Management LP | 197,001 | $8,016,000 | 0.65% |
| TURNER INVESTMENTS LLC | 69,680 | $2,835,000 | 0.57% |
| MIZUHO SECURITIES USA LLC | 49,600 | $2,018,000 | 0.52% |
| Private Capital Advisors, Inc. | 27,900 | $1,135,000 | 0.48% |